Author Interviews, Hematology, Surgical Research, Transfusions / 19.03.2018
TXA Increasingly Use in Shoulder Surgery To Reduce Transfusion Risk and Complications
MedicalResearch.com Interview with:
Shawn Anthony, MD, MBA
Assistant Professor of Orthopaedics
Icahn School of Medicine at Mount Sinai
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Rates of total shoulder arthroplasty are increasing, especially with an aging population. Blood loss requiring transfusion is less common than in total hip or knee replacements but still required in some patients. Tranexamic acid (TXA) is increasingly used to reduce blood loss in lower extremity arthroplasty but limited data exists for its effectiveness and safety in patients undergoing shoulder arthroplasty. We aimed to utilize national data to assess frequency of use and effectiveness of TXA in shoulder arthroplasty patients.
While utilization of TXA has become very common in total hip and knee arthroplasty, TXA is still used in less than 50% of patients undergoing shoulder arthroplasty as of 2016. TXA use was associated with a 36% decrease in transfusion risk and a 35% decreased risk for combined complications. Moreover, TXA use was associated with 6.2% shorter hospital stay.
(more…)